Might be helpful for readers to recall what you said back on 30 March 2022 to help them decide how much credibility your posts have.
You wrote (see here):
"BIT, being a back-bench biotech, has shown it has remarkable compunds and evidence-driven outcome that it was able to send to FDA's court.
The CEO is showing progress!
BIT, this year, can demonstrate many potential breakthrough - potential outcome from the ongoing works in many fronts, securing commercial partnership deals, SP reaching all-time high around $1 per share, ... My gut feeling. DYOR!"
Might be helpful for readers to recall what you said back on 30...
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $25.26M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 412047 | 2.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.7¢ | 42000 | 1 |
View Market Depth
| Last trade - 13.09pm 30/08/2024 (20 minute delay) ? |
| BIT (ASX) Chart |
Day chart unavailable